| Jul 30, 2025 |
Proline for Injection, all strengths and presentations, GenoGenix, LLC, 2840 ... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
B5 Dexpanthenol for Injection, all strengths and presentations, GenoGenix, LL... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Alpha Lipoic Acid for Injection, all strengths and presentations, GenoGenix, ... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Lipo MIC + L-Carnitine for Injection, all strengths and presentations, GenoGe... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
EDTA for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW ... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
RECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Take... |
CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requi... |
Class II |
Cardinal Health Inc. |
| Jul 30, 2025 |
B12 Hydroxocobalamin for Injection, all strengths and presentations, GenoGeni... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Oxytocin for Injection, all strengths and presentations, GenoGenix, LLC, 2840... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Glutathione Preserved for Injection, all strengths and presentations, GenoGen... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Glutathione Magnesium for Injection, all strengths and presentations, GenoGen... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Retatrutide for Injection, 60mg / 10mL vial, all presentations, GenoGenix, LL... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
BPC-157 for Injection, 15mg/10mL vial, all presentations, GenoGenix, LLC, 284... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Vitamin D3 for Injection, all strengths and presentations, GenoGenix, LLC, 28... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Tri-Immune for Injection, all strengths and presentations, GenoGenix, LLC, 28... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
L-Arginine for Injection, all strengths and presentations, GenoGenix, LLC, 28... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Taurine for Injection, all strengths and presentations, GenoGenix, LLC, 2840 ... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Bacteriostatic Water for Injection, all strengths and presentations, GenoGeni... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentatio... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Tesamorelin for Injection, 15mg, 10 mL Multi-Dose Vial, GenoGenix, LLC, 2840 ... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Amino Blend for Injection, all strengths and presentations, GenoGenix, LLC, 2... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Calcium Chloride for Injection, all strengths and presentations, GenoGenix, L... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Biotin for Injection, all strengths and presentations, GenoGenix, LLC, 2840 N... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Lysine for Injection, all strengths and presentations, GenoGenix, LLC, 2840 N... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Methylene Blue for Injection, all strengths and presentations, GenoGenix, LLC... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
NAD+ (Nicotinamide adenine dinucleotide), a) 50 mg/mL, b) 100 mg/mL, 10 mL mu... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
N-Acetyl-L-Cysteine for Injection, all strengths and presentations, GenoGenix... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
L-Carnitine for Injection, all strengths and presentations, GenoGenix, LLC, 2... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Cerebrolysin for Injection, all strengths and presentations, GenoGenix, LLC, ... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Magnesium Chloride for Injection, all strengths and presentations, GenoGenix,... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
GHK-Cu (Copper Peptide) for Injection, all strengths and presentations, GenoG... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Glycine for Injection, all strengths and presentations, GenoGenix LLC, 2840 N... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 30, 2025 |
Reconstitution XO Solution for Injection, all strengths and presentations, Ge... |
Lack of Assurance of Sterility |
Class II |
GenoGenix LLC |
| Jul 29, 2025 |
Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by... |
CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it canno... |
Class II |
Amerisource Health Services LLC |
| Jul 29, 2025 |
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx onl... |
Subpotent drug |
Class II |
Pfizer |
| Jul 25, 2025 |
Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactur... |
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed inter... |
Class II |
Alembic Pharmaceuticals Limited |
| Jul 25, 2025 |
Duloxetine Delayed-Release Capsules, USP, 60 mg, 1,000 Capsules per bottle, R... |
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit. |
Class II |
Breckenridge Pharmaceutical, Inc. |
| Jul 22, 2025 |
BZK Antiseptic Towelette, Sterile, For External Use Only, benzalkonium chlori... |
Lack of Assurance of Sterility. |
Class II |
Taizhou Kangping Medical Science And Technology... |
| Jul 22, 2025 |
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactur... |
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds |
Class II |
Hikma Pharmaceuticals USA Inc. |
| Jul 21, 2025 |
Quick Touch Alcohol Prep Pads(Isopropyl Alcohol 70%), 100 Sterile Pads per ca... |
cGMP Deviations |
Class II |
YANGZHOU YULOU PAPER PRODUCTS CO., LTD |
| Jul 21, 2025 |
Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton... |
Failed Dissolution Specifications: potential for delayed dissolution of the dose after administra... |
Class II |
Merck & Co. Inc |
| Jul 21, 2025 |
Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx... |
Failed Dissolution Specifications: low dissolution results |
Class II |
Ascend Laboratories, LLC |
| Jul 18, 2025 |
Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 u... |
Lack of Processing Controls. |
Class II |
AEQUITA PHARMACY |
| Jul 18, 2025 |
Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 u... |
Lack of Processing Controls. |
Class II |
AEQUITA PHARMACY |
| Jul 18, 2025 |
Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (... |
Lack of Processing Controls. |
Class II |
AEQUITA PHARMACY |
| Jul 18, 2025 |
Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 u... |
Lack of Processing Controls. |
Class II |
AEQUITA PHARMACY |
| Jul 18, 2025 |
Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 ... |
Lack of Processing Controls. |
Class II |
AEQUITA PHARMACY |
| Jul 18, 2025 |
Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL ... |
Lack of Processing Controls. |
Class II |
AEQUITA PHARMACY |
| Jul 18, 2025 |
Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50... |
Lack of Processing Controls. |
Class II |
AEQUITA PHARMACY |
| Jul 18, 2025 |
Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 un... |
Lack of Processing Controls. |
Class II |
AEQUITA PHARMACY |
| Jul 18, 2025 |
Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (... |
Lack of Processing Controls. |
Class II |
AEQUITA PHARMACY |